14-60648804-T-G
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PM1PM2PM5PP3_ModeratePP5
The NM_005982.4(SIX1):c.386A>C(p.Tyr129Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y129C) has been classified as Pathogenic.
Frequency
Consequence
NM_005982.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SIX1 | NM_005982.4 | c.386A>C | p.Tyr129Ser | missense_variant | Exon 1 of 2 | ENST00000645694.3 | NP_005973.1 | |
SIX1 | NM_001425142.1 | c.386A>C | p.Tyr129Ser | missense_variant | Exon 1 of 2 | NP_001412071.1 | ||
MIR9718 | NR_162089.1 | n.*93T>G | downstream_gene_variant | |||||
MIR9718 | unassigned_transcript_2330 | n.*104T>G | downstream_gene_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SIX1 | ENST00000645694.3 | c.386A>C | p.Tyr129Ser | missense_variant | Exon 1 of 2 | NM_005982.4 | ENSP00000494686.1 | |||
SIX1 | ENST00000554986.2 | c.42-2227A>C | intron_variant | Intron 1 of 1 | 3 | ENSP00000452700.2 | ||||
SIX1 | ENST00000553535.2 | n.249-2227A>C | intron_variant | Intron 2 of 2 | 3 | |||||
SIX1 | ENST00000555955.3 | n.1198-2227A>C | intron_variant | Intron 1 of 1 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Branchiootic syndrome 3;C1854594:Autosomal dominant nonsyndromic hearing loss 23 Pathogenic:1Uncertain:1
- -
This sequence change replaces tyrosine, which is neutral and polar, with serine, which is neutral and polar, at codon 129 of the SIX1 protein (p.Tyr129Ser). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with deafness (PMID: 34440452). ClinVar contains an entry for this variant (Variation ID: 666609). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt SIX1 protein function with a positive predictive value of 80%. This variant disrupts the p.Tyr129 amino acid residue in SIX1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 12843324, 15141091, 16652090, 21254961, 21280147). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Branchiootic syndrome 1 Pathogenic:1
- -
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Pathogenic. The p.Tyr129Ser variant in SIX1 has not been previously reported in individuals with hearing lo ss or branchio-oto-renal syndrome. However, a different pathogenic missense var iant at the same amino acid position (c.386A>G, p.Tyr129Cys) has been reported i n 3 probands with branchio-oto-renal syndrome, segregated in >10 affected indivi duals from one family, and in vitro functional evidence supported a deleterious effect of the variant (Ito 2006, Noguchi 2011, Patrick 2009, Ruf 2003, Ruf 2004) . The p.Tyr129Ser variant was absent from population databases. Computational prediction tools and conservation analyses suggest that the p.Tyr129Ser variant may impact the protein, though this information is not predictive enough to dete rmine pathogenicity. In summary, while there is some suspicion for a pathogenic role, the clinical significance of this variant is uncertain. ACMG/AMP criteria applied: PM2; PM5; PP3. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at